Aurobindo Pharma Limited (AUROPHARMA) — Announcement | 29 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Aurobindo Pharma announces Q1FY27 earnings call for August 6, 2026
💡 Investor Takeaway
Investors should note the call will focus on unaudited Q1FY27 results and may include preliminary insights.

Aurobindo Pharma announced its Q1FY27 earnings call scheduled for August 6, 2026 at 8:30 AM IST to discuss unaudited financial results for the quarter ended June 30, 2026, with presentation materials to be posted on its website afterward.

📄 View Original Announcement (PDF)

About Aurobindo Pharma Limited (AUROPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹87,805.59 Cr P/E: 25.3

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day